Comments
Loading...
iShares U.S. Pharmaceutical ETF Informe de interés a corto plazo
IHEARCA
Informe de interés en corto
El interés corto en iShares U.S. Pharmaceutical ETF (ARCA:IHE) ha aumentado durante el último período de informe, aumentando en aumento desde 465.47K hasta 479.85K. Esto representa el -% de las acciones disponibles públicamente de la empresa.
El interés en corto en iShares U.S. Pharmaceutical ETF Corp (ARCX:IHE) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 51.68K acciones negociadas por día, tomaría 9.28 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
479.85K
Interés en corto %
–
Días para cubrir
9.28
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
IHE | iShares U.S. Pharmaceuticals E | 10/15/2025 | 10/24/2025 | — | — | 479,849 | 51,683 | 9.28 | |
IHE | iShares U.S. Pharmaceuticals E | 09/30/2025 | 10/09/2025 | — | — | 465,467 | 45,377 | 10.26 | |
IHE | iShares U.S. Pharmaceuticals E | 09/15/2025 | 09/24/2025 | — | — | 365,912 | 23,882 | 15.32 | |
IHE | iShares U.S. Pharmaceuticals E | 08/29/2025 | 09/10/2025 | — | — | 370,157 | 31,868 | 11.62 | |
IHE | iShares U.S. Pharmaceuticals E | 08/15/2025 | 08/26/2025 | — | — | 427,629 | 36,082 | 11.85 | |
IHE | iShares U.S. Pharmaceuticals E | 07/31/2025 | 08/11/2025 | — | — | 418,332 | 36,640 | 11.42 | |
IHE | iShares U.S. Pharmaceuticals E | 07/15/2025 | 07/24/2025 | — | — | 355,584 | 40,788 | 8.72 | |
IHE | iShares U.S. Pharmaceuticals E | 06/30/2025 | 07/10/2025 | — | — | 362,074 | 70,605 | 5.13 | |
IHE | iShares U.S. Pharmaceuticals E | 06/13/2025 | 06/25/2025 | — | — | 507,089 | 69,362 | 7.31 | |
IHE | iShares U.S. Pharmaceuticals E | 05/30/2025 | 06/10/2025 | — | — | 479,884 | 65,495 | 7.33 | |
IHE | iShares U.S. Pharmaceuticals E | 05/15/2025 | 05/27/2025 | — | — | 389,964 | 148,814 | 2.62 | |
IHE | iShares U.S. Pharmaceuticals E | 04/30/2025 | 05/09/2025 | — | — | 481,680 | 114,189 | 4.22 | |
IHE | iShares U.S. Pharmaceuticals E | 04/15/2025 | 04/25/2025 | — | — | 336,695 | 218,265 | 1.54 | |
IHE | iShares U.S. Pharmaceuticals E | 03/31/2025 | 04/09/2025 | — | — | 229,156 | 55,284 | 4.15 | |
IHE | iShares U.S. Pharmaceuticals E | 03/14/2025 | 03/25/2025 | — | — | 179,450 | 66,117 | 2.71 | |
IHE | iShares U.S. Pharmaceuticals E | 02/28/2025 | 03/11/2025 | — | — | 222,111 | 63,630 | 3.49 | |
IHE | iShares U.S. Pharmaceuticals E | 02/14/2025 | 02/26/2025 | — | — | 183,985 | 59,967 | 3.07 | |
IHE | iShares U.S. Pharmaceuticals E | 01/31/2025 | 02/11/2025 | — | — | 140,942 | 65,880 | 2.14 | |
IHE | iShares U.S. Pharmaceuticals E | 01/15/2025 | 01/27/2025 | — | — | 175,226 | 78,268 | 2.24 | |
IHE | iShares U.S. Pharmaceuticals E | 12/31/2024 | 01/10/2025 | — | — | 234,190 | 82,785 | 2.83 | |
IHE | iShares U.S. Pharmaceuticals E | 12/13/2024 | 12/24/2024 | — | — | 147,320 | 70,228 | 2.1 | |
IHE | iShares U.S. Pharmaceuticals E | 11/29/2024 | 12/10/2024 | — | — | 117,629 | 45,868 | 2.56 | |
IHE | iShares U.S. Pharmaceuticals E | 11/15/2024 | 11/26/2024 | — | — | 120,026 | 46,180 | 2.6 | |
IHE | iShares U.S. Pharmaceuticals E | 10/31/2024 | 11/11/2024 | — | — | 98,267 | 43,350 | 2.27 | |
IHE | iShares U.S. Pharmaceuticals E | 10/15/2024 | 10/24/2024 | — | — | 73,966 | 14,195 | 5.21 | |
IHE | iShares U.S. Pharmaceuticals E | 09/30/2024 | 10/09/2024 | — | — | 68,992 | 23,389 | 2.95 | |
IHE | iShares U.S. Pharmaceuticals E | 09/13/2024 | 09/24/2024 | — | — | 75,335 | 66,809 | 1.13 | |
IHE | iShares U.S. Pharmaceuticals E | 08/30/2024 | 09/11/2024 | — | — | 72,066 | 21,497 | 3.35 | |
IHE | iShares U.S. Pharmaceuticals E | 08/15/2024 | 08/26/2024 | — | — | 90,511 | 47,234 | 1.92 | |
IHE | iShares U.S. Pharmaceuticals E | 07/31/2024 | 08/09/2024 | — | — | 110,998 | 38,590 | 2.88 | |
IHE | iShares U.S. Pharmaceuticals E | 07/15/2024 | 07/24/2024 | — | — | 127,703 | 158,738 | 1 | |
IHE | iShares U.S. Pharmaceuticals E | 06/28/2024 | 07/10/2024 | — | — | 129,720 | 96,736 | 1.34 | |
IHE | iShares U.S. Pharmaceuticals E | 06/14/2024 | 06/26/2024 | — | — | 109,813 | 33,650 | 3.26 | |
IHE | iShares U.S. Pharmaceuticals E | 05/31/2024 | 06/11/2024 | — | — | 102,727 | 52,452 | 1.96 | |
IHE | iShares U.S. Pharmaceuticals E | 05/15/2024 | 05/24/2024 | — | — | 113,263 | 47,970 | 2.36 | |
IHE | iShares U.S. Pharmaceuticals E | 04/30/2024 | 05/09/2024 | — | — | 140,141 | 77,213 | 1.81 | |
IHE | iShares U.S. Pharmaceuticals E | 04/15/2024 | 04/24/2024 | — | — | 96,469 | 116,068 | 1 | |
IHE | iShares U.S. Pharmaceuticals E | 03/28/2024 | 04/09/2024 | — | — | 86,568 | 56,341 | 1.54 | |
IHE | iShares U.S. Pharmaceuticals E | 03/15/2024 | 03/26/2024 | — | — | 113,129 | 70,656 | 1.6 | |
IHE | iShares U.S. Pharmaceuticals E | 02/29/2024 | 03/11/2024 | — | — | 33,806 | 14,184 | 2.38 | |
IHE | iShares U.S. Pharmaceuticals E | 02/15/2024 | 02/27/2024 | — | — | 38,801 | 31,780 | 1.22 | |
IHE | iShares U.S. Pharmaceuticals E | 01/31/2024 | 02/09/2024 | — | — | 47,336 | 20,988 | 2.26 | |
IHE | iShares U.S. Pharmaceuticals E | 01/12/2024 | 01/24/2024 | — | — | 44,056 | 16,762 | 2.63 | |
IHE | iShares U.S. Pharmaceuticals E | 12/29/2023 | 01/10/2024 | — | — | 52,814 | 13,524 | 3.91 | |
IHE | iShares U.S. Pharmaceuticals E | 12/15/2023 | 12/27/2023 | — | — | 60,901 | 22,147 | 2.75 | |
IHE | iShares U.S. Pharmaceuticals E | 11/30/2023 | 12/11/2023 | — | — | 35,691 | 12,239 | 2.92 | |
IHE | iShares U.S. Pharmaceuticals E | 11/15/2023 | 11/27/2023 | — | — | 33,693 | 10,897 | 3.09 | |
IHE | iShares U.S. Pharmaceuticals E | 10/31/2023 | 11/09/2023 | — | — | 134,867 | 113,167 | 1.19 |
En busca de los valores más cortos?